-

ACRO Releases Toolkit to Help Advance Decentralized Clinical Trials

WASHINGTON--(BUSINESS WIRE)--Today, ACRO released its DCT Toolkit, which lays out a vision for how decentralized clinical trials can be planned and executed now and in the future.

When COVID-19 hit in March 2020, clinical trial participants were cut off from in-person clinical research visits. CROs and technology companies were often able to keep active clinical trials up and running by using remote technologies – telemedicine, remote sensors, wearable devices. This allowed patients to continue to get the clinical care and medical evaluation that are part of a clinical trial. Decentralized clinical trials (DCTs) have been an innovative resource during the pandemic, and DCTs will continue to be an important, patient-centric clinical trial design.

The DCT Toolkit is now available on ACRO’s website and contains four resources:

Regulators around the world have shown real flexibility on encouraging the use of remote technologies that help to bring the clinical trial closer to the patient. At the same time, they understandably express concern about the quality and integrity of the data as trials are decentralized.

“With the DCT Data Flow Maps project, ACRO’s Decentralized Clinical Trials Working Party aims to provide transparency and clarity on the processes for keeping data secure, confidential, and accurate,” said Jackie Kent, Chief Customer Officer at Medidata and Vice-Chair of the ACRO Board of Directors.

Jim Streeter, Global Vice President of Product Strategy at Oracle Life Sciences and member of the ACRO DCT Working Party commented: “The Data Flow Maps take a highly visual approach to explaining the ways in which the DCT model guards data integrity and quality. We hope this map-like illustration of data flow will be particularly useful to regulators, customers, and stakeholders.”

For further comment or press inquiries, please contact Karen Noonan, ACRO Senior Vice President of Global Regulatory Policy, at knoonan@acrohealth.org.

About ACRO

The Association of Clinical Research Organizations (ACRO) represents clinical research and technology companies that provide a variety of specialized services to support the development of new pharmaceuticals, biologics, and medical devices. Through its member companies, ACRO helps improve the quality, efficiency, and safety of biomedical research. ACRO member companies operate in more than 100 countries across the globe and conduct or support the conduct of the majority of clinical trials worldwide.

Contacts

Karen Noonan
knoonan@acrohealth.org

Industry:

ACRO

Release Versions
English

Contacts

Karen Noonan
knoonan@acrohealth.org

More News From ACRO

ACRO Announces 2026 Officers

WASHINGTON--(BUSINESS WIRE)--Today, ACRO announced that its Board of Directors elected Cassandra “Sandy” Kennedy, Chief Quality, Regulatory Affairs, and Sustainability Officer at Fortrea, as Chair of the Association, effective January 1, 2026. Gadi Saarony, Chief Executive Officer at Advarra, was elected Vice-Chair. In addition, the Board of Directors elected Marco Capasso, Chief Legal and Risk Officer, Secretary to the Board at Advarra as Secretary of the Association, and Ari Feldman, Senior V...

ACRO Announces Recipients of Diversity & Inclusion Site Resource Grants

WASHINGTON--(BUSINESS WIRE)--Today, ACRO announced the seven clinical research sites that will receive grant funding as part of the ACRO Diversity and Inclusion Site Resource Grants Program. The site grant awardees include: Brooklyn Clinical Research – New York K2 Medical Research – Florida Nebraska Cancer Specialists – Nebraska Preferred Primary Care Physicians – Pennsylvania Randomize Now – Georgia Smart Cures Clinical Research – California Superior Clinical Research – North Carolina With thi...

ACRO Announces 2025 Officers and New Members

WASHINGTON--(BUSINESS WIRE)--ACRO today announced that its Board of Directors elected Jim Reilly, Executive Vice President, Development Cloud Strategy at Veeva, as Chair of the Association, effective January 1, 2025. Cassandra “Sandy” Kennedy, Chief Quality, Regulatory Affairs, and Sustainability Officer at Fortrea, was elected Vice-Chair. In addition, the Board of Directors re-elected Mike Crowley, Chief Administrative Officer, General Counsel, and Secretary at Parexel, as Secretary of the Ass...
Back to Newsroom